Hence, the in vitro targeted therapeutic effect in PBRM1-deficient clear cell renal cell carcinoma (ccRCC) has recently been described, suggesting a possible similar activity in PBRM1-mutated chordoma [29]. The gene discussed is PBRM1; the disease is nonpapillary renal cell carcinoma.